PDF factsheet
      Z

Drug eluting stent in coronary artery disease for bypass graft lesion, clinical trials results

DES versus bare-metal stent
ISAR-CABG, 2011
NCT00611910
Drug-eluting stent (paclitaxel-eluting, sirolimus-eluting, or bioabsorbable polymer sirolimus-eluting stent)
versus
bare metal stent
patients with Bypass Graft Lesions open
Follow-up duration: 12 montsh (35 mo)
paclitaxel eluting stent versus bare-metal stent
SOS, 2008
NCT00247208
Paclitaxel-Eluting Stent (Taxus)
versus
bare metal stent (Express-2)
patients undergoing percutaneous coronary intervention of saphenous vein bypass grafts open
Follow-up duration: 1.5y median
USA, Greece
sirolimus eluting stent versus bare-metal stent
RRISC, 2006
NCT00263263
Cypher
versus
BX-Velocity
Stable or unstable AP, with previous coronary artery bypass surgery and degenerated vein graftsopen
Follow-up duration: 6 months (3 years)
Belgium, The netherlands

  Options


in first

in second

  Filter